The efficacy of treatment versus the prevalence of the condition in Black patients adds evidence to the pile that more diversity is needed in clinical trials.
A new collaboration among Boston cancer centers aims to increase minority populations’ access to the latest treatments for more equitable outcomes.
Structural racism has neglected generations’ suffering from sickle cell disease. Novel therapies are on the horizon, but can they affordably be brought to the masses?
Researchers have identified properties in placenta tissue that may play an important role in preventing the transmission of COVID-19 from a mother with the virus to her fetus.
Infectious disease physician Josh Barocas will use NIDA grant to create a novel surveillance network for people who use drugs, emphasizing community engagement.